54 / 264
4. Paparella MM. Pathogenesis of Meniere’s disease and
Meniere’s syndrome.
Acta Otolaryngol Suppl
. 1984;406:10-25.
5. Thirlwall AS, Kundu S. Diuretics for Meniere’s disease or syn-
drome.
Cochrane Database Syst Rev
. 2006:CD003599.
6. OCEBM Levels of Evidence Working Group.
Explanation of the
2011 Oxford Centre for Evidence-Based Medicine (OCEBM)
Levels of Evidence (Background Document)
. Oxford, UK:
Oxford Centre Evidence-Based Medicine; 2011.
7. Shamseer L, Moher D, Clarke M, et al. Preferred reporting
items for systematic review and meta-analysis protocols
(PRISMA-P) 2015: elaboration and explanation.
BMJ
. 2015;
349:g7647.
8. Klockhoff I, Lindblom U. Menie´re’s disease and hydrochlor-
othiazide (Dichlotride ): a critical analysis of symptoms and
therapeutic effects.
Acta Otolaryngol
. 1967;63:347-365.
9. Kitahara M, Takeda T, Yazawa Y, et al. Treatment of
Meniere’s disease with isosorbide.
ORL J Otorhinolaryngol
Relat Spec
. 1982;44:232-238.
10. Petermann W, Mulch G. Long-term therapy of Meniere’s dis-
ease: comparison of the effects of betahistine dihydrochloride
and hydrochlorothiazide.
Fortschr Med
. 1982;100:431-435.
11. van Deelen G, Huizing E. Use of a diuretic (Dyazide ) in the
treatment of Me´niere’s disease.
ORL J Otorhinolaryngol Relat
Spec
. 1986;48:287-292.
12. Brookes GB, Booth JB. Oral acetazolamide in Meniere’s dis-
ease.
J Laryngol Otol
. 1984;98:1087-1095.
13. Chung SW, Cho CH, Han GC. Hearing and dizziness in
patients with definite Meniere’s disease after the long term use
of diuretics.
J Int Adv Otology
. 2010;6:188-194.
14. Kanda K, Watanabe Y, Shojaku H, et al. Effects of isosorbide
in patients with Meniere’s disease.
Acta Otolaryngol Suppl
.
1993;504:79-81.
15. Kitahara T, Takeda N, Koizuka I, et al. Effects of long-term
treatment with osmotic diuretics on symptoms and electro-
cochleogram in Meniere’s disease.
Equilibrium Research
.
2004;63:237-241.
16. Klockhoff I, Lindblom U, Stahle J. Diuretic treatment of
Meniere disease: long-term results with chlorthalidone.
Arch
Otolaryngol
. 1974;100:262-265.
17. Lassen LF, Hirsch BE, Kamerer DB. Use of nimodipine in the
medical treatment of Me´nie`re’s disease: clinical experience.
Otol Neurotol
. 1996;17:577-580.
18. Norell I, Stahle J. Treatment of Meniere’s disease with hydro-
chlorothiazide.
Acta Otolaryngol
. 1962;54:447-456.
19. Nozawa I, Nakayama H, Hashimoto K, et al. Efficacy of long-
term administration of isosorbide for Meniere’s disease.
ORL J
Otorhinolaryngol Relat Spec
. 1995;57:135-140.
20. Raivio M, Bunne M, Jorgensen B. Evaluation of a three-stage
management program for Meniere’s disease.
Am J Otol
. 1989;
10:443-446.
21. Santos PM, Hall RA, Snyder JM, et al. Diuretic and diet effect
on Meniere’s disease evaluated by the 1985 Committee on
Hearing and Equilibrium guidelines.
Otolaryngol Head Neck
Surg
. 1993;109:680-689.
22. Varga G, Miriszlai E, Szabo´ LZ. Experiences with acetazola-
mid therapy applied in our clinic to patients suffering from
Me´nie`re’s disease for more than 8 years.
J Laryngol Otol
.
1966;80:250-269.
23. Yamazaki T, Imoto T, Hayashi N, Watanabe S, Kozaki H, Abe
T. Menie`re’s disease and isosorbide as an oral hyperosmotic
agent (author’s transl) [in German].
Arch Otorhinolaryngol
.
1982;234:97-104.
24. Corvera J, Corvera G. Long-term effect of acetazolamide and
chlorthalidone on the hearing loss of Meniere’s disease.
Am J
Otol
. 1989;10:142-145.
25. Eryaman E, Gokcan G, Parmaksiz E, et al. Are thiazides effec-
tive on hypertensive vertigo? A preliminary study.
Kulak
Burun Bogaz Ihtis Derg
. 2012;22:219-224.
26. Kakigi A, Takeda T, Saito H, et al. Effect of isosorbide on
hearing loss due to endolymphatic hydrops.
Acta Otolaryngol
Supp
. 1995;519:223-226.
27. Salt AN, Inamura N, Thalmann R, et al. Calcium gradients in
inner ear endolymph.
Am J Otolaryngol
. 1989;10:371-375.
28. Kariya S, Cureoglu S, Fukushima H, et al. Vascular findings
in the stria vascularis of patients with unilateral or bilateral
Meniere’s disease: a histopathologic temporal bone study.
Otol
Neurotol
. 2009;30:1006-1012.
29. Masutani H, Takahashi H, Sando I. Stria vascularis in
Meniere’s disease: a quantitative histopathological study.
Auris
Nasus Larynx
. 1992;19:145-152.
30. Watanabe I. Me´nie`re’s disease.
ORL J Otorhinolaryngol Relat
Spec
. 1980;42:20-45.
31. Committee on Hearing and Equilibrium. Report of
Subcommittee on Equilibrium and Its Measurement. Meniere’s
disease: criteria for diagnosis and evaluation of therapy for
reporting.
Trans Am Acad Ophthalmol Otolaryngol
. 1972;76:
1462-1464.
32. American Academy of Otolaryngology—Head and Neck
Foundation. Committee on Hearing and Equilibrium guidelines
for the diagnosis and evaluation of therapy in Meniere’s dis-
ease.
Otolaryngol Head Neck Surg
. 1995;113:181-185.
33. Pearson BW, Brackmann DE. Committee on Hearing and
Equilibrium guidelines for reporting treatment results in
Meniere’s disease.
Otolaryngol Head Neck Surg
. 1985;93:579-
581.
34. Lexicomp Online.Hudson, OH: Lexi-Comp, Inc; 2015.
35. Barrett RJ, Wright KF, Taylor DR, et al. Cardiovascular and
renal actions of calcium channel blocker chemical subgroups:
a search for renal specificity.
J Pharm Pharmacol
. 1988;40:
408-14.
Otolaryngology–Head and Neck Surgery 154(5)
33